Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Pfizer, Inc.
PFE
$26.27
Name : Pfizer, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $149,359,411,200.00
EPSttm : 1.89
finviz dynamic chart for PFE
Pfizer, Inc.
$26.27
0.61%
$0.16

Float Short %

1.99

Margin Of Safety %

30

Put/Call OI Ratio

0.69

EPS Next Q Diff

-0.12

EPS Last/This Y

-0.03

EPS This/Next Y

0.09

Price

26.26

Target Price

28.79

Analyst Recom

2.48

Performance Q

2.78

Relative Volume

0.99

Beta

0.51

Ticker: PFE




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-09-08PFE24.550.840.632612193
2025-09-09PFE24.720.840.512646818
2025-09-10PFE24.540.840.472672482
2025-09-11PFE24.840.840.292682804
2025-09-12PFE23.910.830.732704612
2025-09-15PFE23.960.820.782722130
2025-09-16PFE23.880.810.552761366
2025-09-17PFE24.050.815216950884940.785265912516362777576
2025-09-18PFE24.120.820.652815513
2025-09-19PFE24.030.820.792860643
2025-09-22PFE24.050.770.312411723
2025-09-23PFE24.120.760.292490065
2025-09-24PFE24.080.720.902612266
2025-09-25PFE23.630.740.572655336
2025-09-26PFE23.740.740.452696531
2025-09-29PFE23.850.750.672645298
2025-09-30PFE25.520.750.142771396
2025-10-01PFE27.210.680.173010146
2025-10-02PFE27.070.680.323147100
2025-10-03PFE27.360.690.173185070
2025-10-06PFE26.460.680.443035522
2025-10-07PFE26.270.690.443148875
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-09-08PFE24.55-32.38443.33.08
2025-09-09PFE24.72-31.68775.53.09
2025-09-10PFE24.59-31.68581.93.09
2025-09-11PFE24.86-31.68855.53.09
2025-09-12PFE23.88-31.68014.33.09
2025-09-15PFE23.98-31.68736.93.09
2025-09-16PFE23.90-31.68614.13.09
2025-09-17PFE24.04-31.68757.13.09
2025-09-18PFE24.14-32.28722.73.09
2025-09-19PFE24.01-32.28570.33.09
2025-09-22PFE24.04-32.28668.53.09
2025-09-23PFE24.14-31.98729.63.09
2025-09-24PFE24.07-31.98621.13.09
2025-09-25PFE23.60-32.88329.33.07
2025-09-26PFE23.76-32.88771.93.07
2025-09-29PFE23.84-32.88716.53.09
2025-09-30PFE25.47-32.89768.73.09
2025-10-01PFE27.22-32.89793.33.09
2025-10-02PFE27.07-32.88575.03.09
2025-10-03PFE27.37-32.88841.83.09
2025-10-06PFE26.43-34.08261.23.09
2025-10-07PFE26.26-34.08554.33.08
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-09-08PFE0.00-0.742.00
2025-09-09PFE0.00-0.742.00
2025-09-10PFE0.00-0.742.00
2025-09-11PFE0.00-0.741.82
2025-09-12PFE0.00-0.741.82
2025-09-15PFE0.00-0.691.82
2025-09-16PFE0.00-0.691.82
2025-09-17PFE0.00-0.691.82
2025-09-18PFE0.00-0.691.82
2025-09-19PFE0.00-0.691.82
2025-09-22PFE0.00-0.721.82
2025-09-23PFE0.00-0.721.82
2025-09-24PFE0.00-0.721.82
2025-09-25PFE0.00-0.721.99
2025-09-26PFE0.00-0.721.99
2025-09-29PFE0.00-0.721.99
2025-09-30PFE0.00-0.721.99
2025-10-01PFE0.00-0.721.99
2025-10-02PFE0.00-0.721.99
2025-10-03PFE0.00-0.721.99
2025-10-06PFE0.00-0.721.99
2025-10-07PFE0.00-0.721.99
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.78

Avg. EPS Est. Current Quarter

0.71

Avg. EPS Est. Next Quarter

0.66

Insider Transactions

Institutional Transactions

-0.72

Beta

0.51

Average Sales Estimate Current Quarter

17042

Average Sales Estimate Next Quarter

17711

Fair Value

34.09

Quality Score

87

Growth Score

63

Sentiment Score

94

Actual DrawDown %

57.5

Max Drawdown 5-Year %

-59

Target Price

28.79

P/E

13.97

Forward P/E

8.35

PEG

P/S

2.34

P/B

1.68

P/Free Cash Flow

12.01

EPS

1.88

Average EPS Est. Cur. Y​

3.08

EPS Next Y. (Est.)

3.18

Target Price Estimates Raised

1

Target Price Estimates Lowered

Profit Margin

16.81

Relative Volume

0.99

Return on Equity vs Sector %

-13.1

Return on Equity vs Industry %

-21.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

8554.3
Pfizer, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 81000
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
stock quote shares PFE – Pfizer Inc. Stock Price stock today
news today PFE – Pfizer Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PFE – Pfizer Inc. yahoo finance google finance
stock history PFE – Pfizer Inc. invest stock market
stock prices PFE premarket after hours
ticker PFE fair value insiders trading